Your browser doesn't support javascript.
loading
CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell-targeted therapies.
Le Cann, Marie; Bouhour, Françoise; Viala, Karine; Simon, Laurence; Tard, Céline; Rossi, Cédric; Morel, Guillaume; Lagrange, Emmeline; Magy, Laurent; Créange, Alain; Michaud, Maud; Franques, Jérôme; Echaniz-Laguna, Andoni; Antoine, Jean-Christophe; Baron, Marine; Arnulf, Bertrand; Puma, Angela; Delmont, Emilien; Maisonobe, Thierry; Leblond, Véronique; Roos-Weil, Damien.
Afiliação
  • Le Cann M; Sorbonne Université, Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, Assitance Publique des Hôpitaux de Paris (AP1HP), Paris, France.
  • Bouhour F; Service d'Electroneuromyographie et Pathologies Neuromusculaires, Hospices Civils de Lyon, Lyon, France.
  • Viala K; Sorbonne Université, Département de Neurophysiologie Clinique, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
  • Simon L; Sorbonne Université, Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, Assitance Publique des Hôpitaux de Paris (AP1HP), Paris, France.
  • Tard C; Department of Neurology and Movement Disorders, U1172, Centre Hospitalo-Universitaire (CHU) de Lille, Centre de Référence des Maladies Neuromusculaires Nord Est Ile de France, Lille, France.
  • Rossi C; Service d'Hématologie, CHU F. Mitterrand, Dijon, France.
  • Morel G; Département d'Oncologie et d'Hématologie, CHU Strasbourg, Hôpital de Hautepierre, Strasbourg, France.
  • Lagrange E; Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France.
  • Magy L; Department of Neurology, Amyotrophic Lateral Sclerosis (ALS) Reference Center, CHU Tours (Bretonneau Hospital), Tours, France.
  • Créange A; EA 4391, Excitabilité Nerveuse et Thérapeutique, Université Paris-Est-Créteil, Créteil, France.
  • Michaud M; Service de Neurologie, Hôpital Henri Mondor, Assistance Publique - Hôpitaux de Paris, Créteil, France.
  • Franques J; Department of Neurology, Nancy University Hospital, Nancy, France.
  • Echaniz-Laguna A; Department of Neurology, La Casamance Hospital, Aubagne, France.
  • Antoine JC; Department of Neurology, AP-HP, CHU de Bicêtre, Le Kremlin Bicêtre, France.
  • Baron M; French National Reference Center for Rare Neuropathies, Le Kremlin Bicêtre, France.
  • Arnulf B; INSERM U1195, Paris-Saclay University, Le Kremlin Bicêtre, France.
  • Puma A; Department of Neurology, University Hospital of Saint-Etienne, Saint-Etienne, France.
  • Delmont E; Sorbonne Université, Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, Assitance Publique des Hôpitaux de Paris (AP1HP), Paris, France.
  • Maisonobe T; Saint-Louis University Hospital AP-HP, Paris, France.
  • Leblond V; Peripheral Nervous System and Muscle Department, Université Côte d'Azur, CHU Nice, Nice, France; and.
  • Roos-Weil D; Referral Centre for Neuromuscular Diseases and ALS, La Timone Hospital, Marseille, France.
Blood ; 136(21): 2428-2436, 2020 11 19.
Article em En | MEDLINE | ID: mdl-32959046
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraproteinemias / Linfócitos B / Rituximab Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraproteinemias / Linfócitos B / Rituximab Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article